chrX-71224122-G-A
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000166.6(GJB1):c.415G>A(p.Val139Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000915 in 1,092,662 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000166.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJB1 | NM_000166.6 | c.415G>A | p.Val139Met | missense_variant | 2/2 | ENST00000361726.7 | NP_000157.1 | |
GJB1 | NM_001097642.3 | c.415G>A | p.Val139Met | missense_variant | 2/2 | NP_001091111.1 | ||
GJB1 | XM_011530907.3 | c.415G>A | p.Val139Met | missense_variant | 2/2 | XP_011529209.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GJB1 | ENST00000361726.7 | c.415G>A | p.Val139Met | missense_variant | 2/2 | 1 | NM_000166.6 | ENSP00000354900 | P1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 exomes AF: 0.00000584 AC: 1AN: 171137Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 57039
GnomAD4 exome AF: 9.15e-7 AC: 1AN: 1092662Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 358430
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease X-linked dominant 1 Pathogenic:4Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 1995 | - - |
Pathogenic, criteria provided, single submitter | research | Laboratório de Neurologia Aplicada e Experimental, Faculdade de Medicina de Ribeirao Preto – Universidade de Sao Paulo | Jul 20, 2021 | 3. The p.Val139Met variant in GJB1 has been reported in several families worldwide with Charcot-Marie-Tooth Neuropathy X linked. ClinVar classifies this variant as Pathogenic (Variation ID:10433), 1 star (criteria provided, 4 submissions), citing 7 articles (12402337, 11325342, 9364054, 9272161, 8816997 and 2 more). This variant is in a hotspot region and an important functional domain of the protein (M3). Besides that, this variant segregates with family phenotype. In summary, the p.Val139Met meets our criteria to be classified as pathogenic. - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 11, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 14, 2023 | PP1_strong, PM5, PS3, PS4 - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | GJB1: PP1:Strong, PM2, PM5, PS4:Moderate - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 14, 2024 | Published functional studies demonstrate this variant exhibits no GJIC capacity function, it demonstrates dominant negative down-regulation of GJIC function when co-expressed with wild type, and it alters the formation and structure of gap junction plaques (PMID: 8816997, 28071741); Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23279425, 11325342, 9364054, 18714809, 7477983, 10093067, 9099841, 10586284, 11438991, 12477701, 8266101, 28071741, 8800924, 10586261, 12402337, 9820654, 34326750, 32376792, 30340945, 8816997, 9272161) - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 15, 2021 | The p.V139M pathogenic mutation (also known as c.415G>A), located in coding exon 1 of the GJB1 gene, results from a G to A substitution at nucleotide position 415. The valine at codon 139 is replaced by methionine, an amino acid with highly similar properties. This variant has been detected in several individuals with Charcot-Marie-Tooth neuropathy X type 1 (CMTX1), and it has been found to segregate with CMTX1 in multiple families (Bergoffen J et al. Science, 1993 Dec;262:2039-42; Fain PR et al. Am J Hum Genet, 1994 Feb;54:229-35; Halbrich M et al. Can J Neurol Sci, 2008 Jul;35:372-4; Hoebeke C et al. Arch Pediatr, 2018 Nov;25:452-458; Hong YB et al. J Peripher Nerv Syst, 2017 09;22:172-181; Silander K et al. Hum Genet, 1997 Sep;100:391-7). Functional studies indicate that this alteration impairs gap junction formation and results in altered pattern of trafficking and localization (Omori Y et al. Mol Biol Cell, 1996 Jun;7:907-16; Deschênes SM et al. J Neurosci, 1997 Dec;17:9077-84; Abrams CK et al. Brain Res, 2001 May;900:9-25; Abrams CK et al. Sci Rep, 2017 01;7:40166). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Charcot-Marie-Tooth Neuropathy X Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 139 of the GJB1 protein (p.Val139Met). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with Charcot-Marie-Tooth disease (PMID: 7477983, 8266101, 9272161, 9364054). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 10433). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GJB1 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects GJB1 function (PMID: 8816997, 11325342). For these reasons, this variant has been classified as Pathogenic. - |
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | Inherited Neuropathy Consortium | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at